PWM
IDXX icon

Perigon Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Perigon Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$869K Buy
1,651
+72
+5% +$40.4K 0.01% 645
2026
Q1 		$887K Sell
1,579
-17
-1% -$10.9K 0.02% 569
2025
Q4 		$1.08M Buy
1,596
+67
+4% +$45.6K 0.02% 519
2025
Q3 		$977K Buy
1,529
+71
+5% +$43.1K 0.02% 518
2025
Q2 		$782K Buy
1,458
+45
+3% +$21.5K 0.02% 543
2025
Q1 		$593K Sell
1,413
-61
-4% -$26.5K 0.02% 590
2024
Q4 		$632K Buy
1,474
+26
+2% +$11.4K 0.02% 575
2024
Q3 		$732K Sell
1,448
-6
-0.4% -$2.92K 0.02% 512
2024
Q2 		$708K Buy
1,454
+56
+4% +$28.1K 0.02% 451
2024
Q1 		$755K Buy
1,398
+14
+1% +$7.65K 0.02% 437
2023
Q4 		$768K Buy
1,384
+891
+181% +$418K 0.03% 401
2023
Q3 		$216K Buy
+493
New +$246K 0.01% 709
2021
Q1 		– Sell
-45
Closed -$22K – 741
2020
Q4 		$22K Buy
+45
New +$20.1K ﹤0.01% 1009

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Perigon Wealth Management's IDXX Position: Q2 2026 in Review

Perigon Wealth Management increased its Idexx Laboratories (IDXX) stake by 4.6% in Q2 2026, buying an estimated $40.4K and bringing the position to 1,651 shares worth $869K. The position accounts for 0.01% of the portfolio, ranked #645.

Perigon Wealth Management first reported a position in IDXX in Q4 2020 and has held it in 13 quarters since. The position peaked at $1.08M in Q4 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Perigon Wealth Management held 1,651 shares of Idexx Laboratories worth $869K as of Q2 2026.
  • Perigon Wealth Management bought 72 Idexx Laboratories shares in Q2 2026, an estimated $40.4K.
  • Idexx Laboratories made up 0.01% of Perigon Wealth Management's portfolio in Q2 2026, its #645 holding.
  • Perigon Wealth Management first reported a position in Idexx Laboratories in Q4 2020 and has held it in 13 quarters since.
  • Perigon Wealth Management's Idexx Laboratories position peaked at $1.08M in Q4 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Perigon Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.